A recent study published in Nature Microbiology on June 25. has shed light on a critical aspect of herpesvirus infections. Herpesviruses are a widespread family of viruses that can cause various diseases, ranging from cold sores to life-threatening complications in individuals with weakened immune systems.
The research team, led by the Leibniz Institute of Virology, has revealed key details about how herpesviruses exit the cell nucleus without damaging the nuclear envelope. The study used advanced electron cryo-tomography to visualize the involved structures. These insights could lead to the development of more effective antiviral therapies for herpesvirus infections, which are widespread and pose significant health risks, especially for immunocompromised individuals.

The study focuses on Herpes simplex virus 1 (HSV-1) and Pseudorabies virus (PrV), examining the herpesviral nuclear egress complex (NEC) protein coat on the inner nuclear membrane. These structures are crucial for releasing viral capsids into the cytosol, where they acquire their envelope before exiting the cell. Using advanced imaging techniques like electron cryo-tomography, the researchers reveal how the NEC interacts with the capsid surface, allowing the capsids to be transported from the nucleus without damaging the nuclear envelope. The study highlights the NEC’s structural flexibility, suggesting an adaptive mechanism for herpesvirus egress.
The new research provides the first detailed structural analysis of the interface between the herpesviral nuclear egress complex (NEC) and virus particles within the cellular environment. The findings offer valuable insights into the nuclear egress mechanism, which is common to all herpesviruses. These nanoscale insights could serve as a foundation for developing antiviral interventions, with potential applications for other human-pathogenic herpesviruses as well.
It is worth mentioning that currently there are only a limited number of antiviral medications available for treating herpesvirus infections. While these medications can help reduce symptoms and shorten the infection’s duration, they do not completely eliminate the virus from the body. As a result, there is a continued need for new therapies to more effectively address resistance to the existing antiviral treatments.
Extracted from Research Article “Molecular plasticity of herpesvirus nuclear egress analyzed in situ” published in Nature Microbiology – 25 June 2024”
published in the scientific journal Applied and Environmental Microbiology – 24 November 2021.
Keywords
Herpesvirus infections, Herpes simplex virus 1 (HSV-1), Pseudorabies virus (PrV), nuclear egress complex (NEC), electron cryo-tomography, viral capsids, nuclear envelope, cytosol, protein coat, antiviral therapies, immunocompromised individuals, structural flexibility, adaptive mechanism, virus particles, cellular environment, nuclear egress mechanism, human-pathogenic herpesviruses, structural analysis, antiviral interventions, herpesvirus resistance, antiviral medications, viral elimination, herpesvirus treatments


